EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of colorectal cancer aggressiveness by Oleanolic acid through Nur77 degradation

Shan Deng, Yuping Liu, Xiyu Liu, Jialin Yu, Yan Chen, Jiege Huo

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.156192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Shan Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China. Electronic address: sharonde…. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 1, Oleanolic Acid, Colorectal Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer (CRC) is the second primary malignancy in China with tough treatment challenge. Although Oleanolic acid (OA) protects against various cancers, its mechanisms in CRC are not well defined. Our previously study showed that Nur77 has CRC promoting effect. Thus, we investigated the roles of OA as Nur77 ligand and the regulatory effects on Nur77 degradation in CRC progression. METHODS: The proliferative and metastatic phenotypes of OA was examined by CCK-8, EdU, organoid culture, would healing and transwell assays, respectively. Epithelial-mesenchymal transition (EMT) properties were assessed by Western blotting (WB). The interaction between OA and Nur77 was monitored by molecular docking and Molecular Dynamics stimulation (MD). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene set enrichment analysis (GSEA) were employed to screen the downstream regulatory pathways. The half-time and proteasome degradation of Nur77 were treated with cycloheximide (CHX) and MG132. Co-immunoprecipitation (Co-IP) and ubiquitination assays were employed to detect direct association between Nur77 and PPARγ. Rescued experiments were performed by Nur77 agonist Cytosporone B (Csn-B) treatment. The findings were verified in xenograft and in situ models. RESULTS: For the first time, we found the effect of OA on ubiquitination degradation. OA inhibited CRC cell survival and EMT phenotypes by suppressing Nur77. Mechanistically, OA directly bind to Nur77 and facilitated the ubiquitin degradation of Nur77. During this process, PPARγ acted as the ubiquitination activator via interacting with Nur77. Rescued experiments revealed that OA-induced inhibition was recovered by replenishing Nur77. In both subcutaneous and orthotopic CRC models, OA exhibited significant anti-tumor effect together with Nur77 inhibition. CONCLUSION: We revealed a new regulatory effect of OA in CRC tumorigenesis via PPARγ-mediated Nur77 ubiquitin degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 4, Group A, Member 1Oleanolic AcidColorectal NeoplasmsEpithelial-Mesenchymal TransitionMolecular Docking SimulationHumansAnimalsPPAR gammaMiceCell Line, TumorCell ProliferationMice, NudeMice, Inbred BALB CMaleUbiquitinationXenograft Model Antitumor AssaysPhenylacetates

Stichwörter der Autor:innen

Colorectal cancerNur77Oleanolic acidUbiquitination

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 1Oleanolic AcidNR4A1 protein, humanPPAR gammacytosporone BPhenylacetates

Autor:innen und Institutionen

  • The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China. Electronic address: sharondengs@njucm.edu.cn.
  • The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
  • Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing, 210008…
  • The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China; Research Center for Multicomponent of Traditional Chinese Medicine and Microecology, Jiangsu Provi…
  • The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, 100 Shizi Road,…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, S., Liu, Y., Liu, X., Yu, J., Chen, Y., & Huo, J. (2024). Inhibition of colorectal cancer aggressiveness by Oleanolic acid through Nur77 degradation. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156192

Vancouver

Deng S, Liu Y, Liu X, Yu J, Chen Y, Huo J. Inhibition of colorectal cancer aggressiveness by Oleanolic acid through Nur77 degradation. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.156192

BibTeX
@article{Deng2024,
  author = {Deng, Shan and Liu, Yuping and Liu, Xiyu and Yu, Jialin and Chen, Yan and Huo, Jiege},
  title = {Inhibition of colorectal cancer aggressiveness by Oleanolic acid through Nur77 degradation},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.156192}
}
Kostenlos starten →